Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Ipsen    IPN   FR0010259150


SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Ipsen : Attractive timing to go long again

11/02/2020 | 02:52am EST
long trade
Target price hit
Entry price : 78.5€ | Target : 88€ | Stop-loss : 73€ | Potential : 12.1%
The Ipsen share is coming back to a technical support zone comprising the lower bound of the trading range. This provides a good timing to go long on the stock.
Investors have an opportunity to buy the stock and target the € 88.
Ipsen : Ipsen : Attractive timing to go long again
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.

  • The group's high margin levels account for strong profits.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

  • The company's earnings releases usually do not meet expectations.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
  • Revenue estimates are regularly revised downwards for the current and coming years.
  • For the last few months, analysts have been revising downwards their earnings forecast.

© MarketScreener.com 2020

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Sales 2020 2 633 M 3 179 M 3 179 M
Net income 2020 450 M 543 M 543 M
Net Debt 2020 753 M 909 M 909 M
P/E ratio 2020 13,5x
Yield 2020 1,44%
Capitalization 5 972 M 7 220 M 7 211 M
EV / Sales 2020 2,55x
EV / Sales 2021 2,27x
Nbr of Employees 5 807
Free-Float 42,0%
Upcoming event on IPSEN
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 90,31 €
Last Close Price 72,30 €
Spread / Highest target 56,3%
Spread / Average Target 24,9%
Spread / Lowest Target 5,12%
EPS Revisions
Managers and Directors
David G. Loew Chief Executive Officer & Director
Marc M. P. de Garidel Non-Executive Chairman
Aymeric Le Chatelier Chief Financial Officer & Executive Vice President
Aidan Murphy Executive Vice President-Technical Operations
Howard Mayer Executive Vice President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
IPSEN6.48%7 220
JOHNSON & JOHNSON1.86%421 997
ROCHE HOLDING AG2.48%305 385
NOVARTIS AG1.97%218 041
MERCK & CO., INC.1.93%210 954
PFIZER INC.-0.30%203 993